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Started at the grassroot level, increased awareness and investment in research has resulted in unprecedented rec-
ognition of endometriosis by the European Parliament, taken up by the Italian Senate in a 5-year action plan. This
offers welcome assurance to the scientific community. (Fertil Steril 2007;85:1285–7. 2007 by American Soci-
ety for Reproductive Medicine.)THE CHALLENGE OF ENDOMETRIOSIS
Endometriosis is defined as the presence of endometrial-like
tissue outside the uterus, which induces a chronic inflamma-
tory reaction. The condition is predominantly found in women
of reproductive age, in all ethnic and social groups (1). It is as-
sociated with pelvic pain and infertility, which can impact on
the physical, mental, and social well being of a woman and can
have a profound effect on her life, including the ability to fin-
ish an education, maintain a career, or to bear children (1).
The endometriosis-associated costs to society, including
delayed diagnosis and ‘‘hit-and-miss’’ treatments (2–4), are
considerable but yet poorly identified, as are the costs to the
individual when disease symptoms interfere with day-to-day
life at work or at home. Based on a review of cost estimates,
the annual costs of endometriosis attained $22 billion in
2002 in the United States. These costs are considerably higher
than those related to Crohn’s disease or to migraine (4).
In three steps we aim to describe how community action in
Europe has addressed the need for more awareness and recog-
nition of this social and economic effect of endometriosis.
STEP ONE: GETTING THE EUROPEAN PARLIAMENT
INVOLVED
In 2004, members of the most active national endometriosis
support organizations in Europe approached the European
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metriosis. This prompted a group of Members of the Euro-
pean Parliament to publish a Written Declaration on
Endometriosis (5) in March 2005 calling for:
1. Member States’ governments and the European Com-
mission to promote Endometriosis Awareness Week
and to support awareness-raising initiatives by national
organizations;
2. Major information campaigns targeting the public,
health professionals, and legislators;
3. The European Commission to include prevention of en-
dometriosis in future Community Action Programs for
Public Health to allow more research into the causes,
prevention, and treatment of endometriosis.
STEP TWO: BUILDING A STRATEGIC ALLIANCE
All national endometriosis support groups in Europe, joined
together as the European Endometriosis Alliance in October
2004, subsequently got involved in the campaign, and high-
lighted the challenges associated with endometriosis to their
local Members of the European Parliament and urged them to
sign The Written Declaration. This effort was supported by
endometriosis specialists across Europe, who lent their sup-
port by writing to parliamentarians emphasizing the impor-
tance of The Written Declaration.
This new strategic alliance between patients and physi-
cians to reach out to politicians with respect to an important
women’s health issue has been unprecedented in Europe—
and it worked. By the deadline of June 9, 2005, 36% of
Members of the European Parliament had signed the Written
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This is the highest number of signatures achieved for a
human health issue and the sixth most successful Written
Declaration since 1998.
Subsequently this enabled the European Endometriosis Al-
liance to meet with officials in the European Commission,
and in January 2006, the European Union Community Public
Health Programme included a specific reference to the need
for ‘‘information and definition of indicators to improve rel-
evant information for specific aspects of women’s gynaeco-
logical and menopausal health (e.g., endometriosis).’’
For the first time ‘‘women’s health’’ was on the European
Commission’s agenda—and with endometriosis as a specific
example.
STEP THREE: MAKING IT HAPPEN—ITALY LEADS THEWAY
The Investigation
Based on the initiative taken by the European Parliament, and
encouraged by Italian gynecological societies, the Associa-
zione Italiana Endometriosi Onlus and the European Endo-
metriosis Alliance, a group of Italian senators submitted
a motion to the Italian Senate informing their members about
the contents of the European Union Written Declaration.
Consequently, the Senate’s Standing Committee on Hygiene
and Health responded to the invitation of the European Par-
liament to raise awareness of the problem by organizing
a fact finding investigation (6) to:
1. assess the impact of endometriosis in Italy from both
a social and an economic standpoint, and, thus, evaluate
potential direct and indirect costs;
2. provide information and guidance for the adoption of
public policies consistent with the European and world-
wide guidelines;
3. identify Socio-economic health indicators for the dis-
ease, potentially instrumental in reducing expenses
and in directing dedicated economic resources.
The Result
The Senate Committee’s investigation concluded that endo-
metriosis has to be recognized as a disease with an important
economic impact on the family and working life of a woman
(e.g., lost days at work, lay-offs, having to change jobs, sick
leave, time off for having surgery). The Committee also rec-
ognized a significant association with health costs related to
a diagnostic delay and therapeutic expenses including sur-
gery, drugs, and assisted reproductive technologies (ART).
The cost incurred by the Italian National Health System for
hospital admissions for endometriosis was estimated at
2,773.80 euros for each patient, totaling some 54 million
euros per year.
The 5-Year Plan
Concluding that endometriosis needs to be viewed as a social
disease, the Senate Committee has proposed the following
policy for implementation during the next 5 years (6):1286 Bianconi et al. Recognizing endometriosis as a soci1. Identification of specific disease indicators such as
a dedicated diagnosis-related group (DRG) for reim-
bursement, appropriately differentiated in accordance
with the various types of surgical interventions includ-
ing the establishment of similar reimbursement tariffs
nationwide;
2. Promoting collaboration between the Ministry of Labor
and Social Policies, the National Institute for Insurance
against Accidents at Work (INAIL), and the Institute of
Social Medicine (INPS), and to highlight the burden-
some effects on working conditions and on absence
from work;
3. Developing a process that will establish national refer-
ral centers for the first treatment and centers of excel-
lence for subsequent follow-up, including training of
pelvic surgeons;
4. Encouraging research by allocating ad hoc funds and
promoting specific actions for the prevention of endo-
metriosis in the context of the Community Action Plans
for Public Health;
5. Setting up regional registers and a dedicated national
register;
6. Developing solutions for providing pharmacological
treatment free of charge for those with long-term
(chronic) needs for oral contraceptives (OC), GnRH an-
alogues and other drugs for symptomatic relief;
7. Developing a package of supporting measures for
women with particularly severe or recurrent forms of
endometriosis that would include: free follow-up diag-
nostic tests; free medical products to safeguard the
health and fertility of these women; and, the assignment
of a stage of disability under Act no. 104 of February 5,
1992, for severe cases where the psychological and
physical state of health of the patient, who undergoes
several surgical interventions, is severely undermined
and when there are major relapses and recurrent chronic
pelvic pain;
8. Carrying out health education and information cam-
paigns in schools and for the public;
9. Establishing a National Endometriosis Day for women
affected by endometriosis.
STEPPING FORWARD
In this article we have documented a process, which is based
on community action, where all stake holders have recog-
nized that to truly address a disease as prevalent as endome-
triosis, a strategic alliance between patients, physicians,
scientists, and legislators is essential, if progress for millions
of women with endometriosis across the world is to become
reality. A disease, which has such a profound effect on soci-
ety, needs to be recognized and dealt with by society.
The very core of the Italian Senate’s Investigative Commit-
tee’s findings summarizes the challenge of endometriosis:
there is no cure, treatments are often ‘‘hit-and-miss,’’ those
who treat endometriosis are often inadequately reimbursed,
and there is too little data available to truly establish theal disease Vol. 85, No. 5, November 2007
tremendous personal, financial, and socioeconomic burden
that endometriosis leaves in its wake.
In reaction to this we have seen, as a first in the European
Union’s history, a patient-triggered action, in collaboration
with physicians and open-minded politicians, which has re-
sulted in the recognition of endometriosis at a European
Union level; and a country—Italy—has responded to the
European Union’s call for action and moved forward at a
national level.
The new strategic alliances, which have been formed as
a result of the European Union and Italian initiatives, are
an important step forward in addressing all aspects of endo-
metriosis, including a call for action to:
 fund causal and preventive research;
 recognize that a chronic, multifactorial disease such as
endometriosis needs to be treated in centers of excel-
lence by a multidisciplinary team, and work toward
the establishment of such centers based on peer-re-
viewed treatment guidelines (7);
 fund national and international awareness campaigns to
reduce time to diagnosis, reduce ‘‘hit-and-miss’’ treat-
ments, and ensure timely multidisciplinary expert care;
 establish national and international registries to monitor
morbidity and effectiveness of treatment with a subse-
quent aim to preserve fertility, improve quality of life,
and reduce personal and socioeconomic burden.
The achievement in the European Union, and in Italy, is an
excellent example of a new era of collaboration betweenFertility and Sterilitystake holders, which could have an unprecedented impact
on the scientific community. It is now time for the European
Union and the countries therein—indeed countries across
the world—to heed the call for action set out in the 2005
Written Declaration and provide resources for and regula-
tion of the treatment of endometriosis. It is now time for
all nations to follow the Italian example and recognize endo-
metriosis as a disease that needs to be dealt with by society
as a whole.
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